| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2009PNAS..10612921G |
| P356 | DOI | 10.1073/PNAS.0901454106 |
| P932 | PMC publication ID | 2722285 |
| P698 | PubMed publication ID | 19617566 |
| P5875 | ResearchGate publication ID | 26681335 |
| P50 | author | Bert Vogelstein | Q827502 |
| James Agnew | Q6128409 | ||
| Victor Velculescu | Q7926425 | ||
| Kenneth W. Kinzler | Q28031580 | ||
| Jill S. Barnholtz-Sloan | Q61089748 | ||
| Georgia L. Wiesner | Q87127153 | ||
| Helen R Moinova | Q96071145 | ||
| Sanford D Markowitz | Q96071153 | ||
| P2093 | author name string | Earl Lawrence | |
| James Lutterbaugh | |||
| Joseph Willis | |||
| Thomas A Gerken | |||
| Lakshmeswari Ravi | |||
| Kishore Guda | |||
| Giovanni Parmigiani | |||
| John B Lowe | |||
| Jian He | |||
| Susan Lewis | |||
| Nikolas Papadopoulos | |||
| Oliver Jamison | |||
| Leanna Natale | |||
| Dawn W Dawson | |||
| P2860 | cites work | Dynamic association between the catalytic and lectin domains of human UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase-2 | Q24301958 |
| Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability | Q24319995 | ||
| Molecular cloning, sequence, and expression of a human GDP-L-fucose:beta-D-galactoside 2-alpha-L-fucosyltransferase cDNA that can form the H blood group antigen | Q24321389 | ||
| Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability | Q24618618 | ||
| The genomic landscapes of human breast and colorectal cancers | Q27861078 | ||
| Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12 | Q28215700 | ||
| cDNA cloning and expression of a novel UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase | Q28504745 | ||
| The lectin domain of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 is involved in O-glycosylation of a polypeptide with multiple acceptor sites | Q28571370 | ||
| Colorectal cancer in mice genetically deficient in the mucin Muc2 | Q28588769 | ||
| Cloning and expression of a novel, tissue specifically expressed member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family | Q32003112 | ||
| Pathways of O-glycan biosynthesis in cancer cells | Q33783697 | ||
| All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases | Q34183333 | ||
| Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions | Q34683362 | ||
| Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation | Q37232595 | ||
| Multiple rare variants in different genes account for multifactorial inherited susceptibility to colorectal adenomas | Q37619454 | ||
| P433 | issue | 31 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12921-12925 | |
| P577 | publication date | 2009-07-17 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers | |
| P478 | volume | 106 |
| Q35152903 | A glycogene mutation map for discovery of diseases of glycosylation |
| Q58695574 | A molecular switch orchestrates enzyme specificity and secretory granule morphology |
| Q37000187 | A multistage genetic association study identifies breast cancer risk loci at 10q25 and 16q24 |
| Q33979369 | A two-phase case-control study for colorectal cancer genetic susceptibility: candidate genes from chromosomal regions 9q22 and 3q22. |
| Q37100578 | Aberrant O-glycosylation and anti-glycan antibodies in an autoimmune disease IgA nephropathy and breast adenocarcinoma |
| Q47228598 | Altered glycosyltransferases in colorectal cancer |
| Q33911414 | An O-glycosyltransferase promotes cell adhesion during development by influencing secretion of an extracellular matrix integrin ligand |
| Q37039848 | An integrated approach to identify causal network modules of complex diseases with application to colorectal cancer |
| Q36719681 | Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer |
| Q36153320 | Biomarkers, bundled payments, and colorectal cancer care |
| Q33688535 | C1GALT1 overexpression promotes the invasive behavior of colon cancer cells through modifying O-glycosylation of FGFR2. |
| Q38869978 | COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer. |
| Q47132911 | Clinical significance and biological function of fucosyltransferase 2 in lung adenocarcinoma |
| Q90331269 | Collaborative Group of the Americas on Inherited Gastrointestinal Cancer Position statement on multigene panel testing for patients with colorectal cancer and/or polyposis |
| Q33959070 | Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. |
| Q26864268 | Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family |
| Q92462628 | Current status of the genetic susceptibility in attenuated adenomatous polyposis |
| Q45316549 | Defective GALNT12 causes CRCS1 |
| Q50289229 | Defective GALNT12 does not transfer GalNAc to mucins |
| Q60472142 | Discovery of common and rare genetic risk variants for colorectal cancer |
| Q35022335 | Eleven candidate susceptibility genes for common familial colorectal cancer |
| Q34800380 | Emerging paradigms for the initiation of mucin-type protein O-glycosylation by the polypeptide GalNAc transferase family of glycosyltransferases |
| Q38076635 | Enzymatic glycosylation of multivalent scaffolds |
| Q88635627 | Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer |
| Q39141218 | Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis |
| Q50233622 | Familial Colorectal Cancer Type X. |
| Q37650472 | First comprehensive in silico analysis of the functional and structural consequences of SNPs in human GalNAc-T1 gene |
| Q54783186 | GALNT12 is not a major contributor of familial colorectal cancer type X. |
| Q60922773 | GALNT6 Promotes Tumorigenicity and Metastasis of Breast Cancer Cell via β-catenin/MUC1-C Signaling Pathway |
| Q39506081 | IDH1 gene mutations: a new paradigm in glioma prognosis and therapy? |
| Q41450595 | Identification of GALNT14 as a novel neuroblastoma predisposition gene |
| Q45345393 | Inherited deleterious variants in GALNT12 are associated with CRC susceptibility |
| Q30519549 | Inherited genetic variation and overall survival following follicular lymphoma |
| Q33569664 | Isoform-specific O-glycosylation of osteopontin and bone sialoprotein by polypeptide N-acetylgalactosaminyltransferase-1. |
| Q33779382 | Large numbers of individuals are required to classify and define risk for rare variants in known cancer risk genes |
| Q28740409 | Lectin domains of polypeptide GalNAc transferases exhibit glycopeptide binding specificity |
| Q35071116 | Linkage analysis in familial non-Lynch syndrome colorectal cancer families from Sweden |
| Q55517874 | Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. |
| Q47359626 | Loss of the mucosal barrier alters the progenitor cell niche via Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling. |
| Q36413436 | MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients. |
| Q30422393 | Multiple members of the UDP-GalNAc: polypeptide N-acetylgalactosaminyltransferase family are essential for viability in Drosophila |
| Q34623603 | Mutation spectrum in human colorectal cancers and potential functional relevance |
| Q37619873 | N-acetylgalactosaminyltransferases in cancer |
| Q37602721 | New genes emerging for colorectal cancer predisposition |
| Q36497067 | O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components |
| Q33665521 | O-glycosylation regulates polarized secretion by modulating Tango1 stability |
| Q47281580 | Over forty years of bladder cancer glycobiology: Where do glycans stand facing precision oncology? |
| Q47709506 | Pleiotropic effects of O-glycosylation in colon cancer |
| Q40108489 | Polypeptide N-acetylgalactosaminyltransferase-6 expression in gastric cancer |
| Q55284634 | Polypeptide-GalNAc-T6 expression predicts better overall survival in patients with colon cancer. |
| Q36056470 | Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells |
| Q35413473 | Protein glycosylation in cancer |
| Q52652189 | Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population. |
| Q47136087 | Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome. |
| Q36850408 | Site-specific O-glycosylation on the MUC2 mucin protein inhibits cleavage by the Porphyromonas gingivalis secreted cysteine protease (RgpB). |
| Q30404960 | Structural and functional impact of cancer-related missense somatic mutations |
| Q41194359 | Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours |
| Q41696433 | Targeted sequencing of 36 known or putative colorectal cancer susceptibility genes. |
| Q38197051 | The Cosmc connection to the Tn antigen in cancer |
| Q36542361 | The N's and O's of Drosophila glycoprotein glycobiology |
| Q36045285 | The cellular microenvironment and cell adhesion: a role for O-glycosylation |
| Q28077234 | The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery |
| Q37000627 | The lectin domain of the polypeptide GalNAc transferase family of glycosyltransferases (ppGalNAc Ts) acts as a switch directing glycopeptide substrate glycosylation in an N- or C-terminal direction, further controlling mucin type O-glycosylation |
| Q90666764 | The missing heritability of familial colorectal cancer |
| Q33987647 | The role of mucin-type O-glycans in eukaryotic development |
| Q90240459 | The structure of the colorectal cancer-associated enzyme GalNAc-T12 reveals how nonconserved residues dictate its function |
| Q38711454 | Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer. |
| Q52655047 | Two novel colorectal cancer risk loci in the region on chromosome 9q22.32. |
| Q48240037 | Use of multigene-panel identifies pathogenic variants in several CRC-predisposing genes in patients previously tested for Lynch Syndrome. |
| Q42020935 | Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancer |
| Q42020322 | miRNA-mediated GALNT modulation of invasion and immune suppression: A sweet deal for metastatic cells |
Search more.